Dosimetric evidences of 131I-MIBG treatment in High Risk Neuroblastoma in VERITAS protocol

被引：0
|
作者：
Saletti, P. [1 ]
Olianti, C. [1 ]
Tondo, A. [2 ]
Simontacchi, G. [1 ]
Belli, G. [1 ]
机构：
[1] AOU Careggi, Florence, Italy
[2] AOU Meyer, Florence, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-702
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [21] Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma
    Roberto Accorsi
    Michael J. Morowitz
    Martin Charron
    John M. Maris
    Pediatric Radiology, 2003, 33 : 688 - 692
  • [22] Individualised 131I-mIBG Therapy in the Management of Refractory and Relapsed Neuroblastoma
    George, S. L.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S. J.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [23] A phase II study of 131I-MIBG for refractory neuroblastoma.
    Maris, JM
    Yanik, G
    Messina, J
    Kersun, L
    Goldsby, RE
    Huberty, J
    Veatch, J
    Brophy, P
    Cheng, SC
    Hawkins, RE
    Matthay, KK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 801S - 801S
  • [24] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [25] Biomarkers of radiation exposure in children with neuroblastoma treated with 131I-mIBG
    Karski, Erin E.
    Matthay, Katherine K.
    Allen, M. Shelly
    Coleman, Matthew
    Kohlgruber, Ayona
    Haas-Kogan, Daphne A.
    Olow, Aleksandra E.
    DuBois, Steven G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] High dose dosimetry-guided 131I-MIBG treatment for refractory primary neuroblastoma: a case report
    Boni, G.
    Borso, E.
    Mazzarri, S.
    Menconi, M.
    Casazza, G.
    Favre, C.
    Traino, C. A.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [27] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [28] Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma 131I-mIBG treatment
    Maria Chimeno, Jose
    Sebastia, Natividad
    Torres-Espallardo, Irene
    Balaguer, Julia
    Candela-Juan, Cristian
    Luis Loaiza, Jose
    Adria, Mar
    Ibanez-Rosello, Blanca
    Canete, Adela
    Marti-Bonmati, Luis
    Montoro, Alegria
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 95 (03) : 314 - 320
  • [29] Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
    George, Sally L.
    Falzone, Nadia
    Chittenden, Sarah
    Kirk, Stephanie J.
    Lancaster, Donna
    Vaidya, Sucheta J.
    Mandeville, Henry
    Saran, Frank
    Pearson, Andrew D. J.
    Du, Yong
    Meller, Simon T.
    Denis-Bacelar, Ana M.
    Flux, Glenn D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (05) : 466 - 472
  • [30] HIGH DOSE 131I-MIBG TREATMENT IN STAGE 4 NEUROBLASTOMA PATIENTS IN A TERTIARY CENTRE IN HONG KONG
    Leung, W. K.
    Lee, V.
    Kam, M. K. M.
    Cheung, J. S. S.
    Cheng, F. W. T.
    Shing, M. K.
    Li, C. K.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 112
12345